First Pacific Advisors, LP Edwards Lifesciences Corp Transaction History

First Pacific Advisors, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $157,257 - $233,194	-1,818 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $4,086 - $5,200	-57 Reduced 3.04%	1,818 $166,000
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $71,925 - $96,187	1,250 Added 200.0%	1,875 $130,000
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $32,756 - $50,625	625 New	625 $118,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of First Pacific Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on First Pacific Advisors, LP with notifications on news.